Ultralife (NASDAQ:ULBI) Issues Quarterly Earnings Results

Ultralife (NASDAQ:ULBI) released its quarterly earnings data on Thursday. The technology company reported $0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by ($0.09), FiscalAI reports. Ultralife had a negative net margin of 3.50% and a positive return on equity of 2.75%. The company had revenue of $48.27 million during the quarter, compared to analysts’ expectations of $56.00 million.

Ultralife Stock Up 0.1%

ULBI stock traded up $0.01 during trading on Thursday, hitting $15.63. 242,421 shares of the company’s stock traded hands, compared to its average volume of 65,842. The firm has a market capitalization of $260.40 million, a P/E ratio of -39.08 and a beta of 0.63. The business has a fifty day simple moving average of $7.24 and a two-hundred day simple moving average of $6.60. The company has a quick ratio of 1.30, a current ratio of 2.87 and a debt-to-equity ratio of 0.32. Ultralife has a 1 year low of $4.90 and a 1 year high of $15.69.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (d)” rating on shares of Ultralife in a report on Wednesday, September 9th. One investment analyst has rated the stock with a Sell rating. According to MarketBeat, the company has a consensus rating of “Sell”.

About Ultralife

Ultralife Corporation is a New York-based manufacturer of power and communications products serving government, defense, aerospace, industrial, medical and other specialized markets. The company develops and produces batteries, battery packs, chargers and related power-management products designed for portable and mission-critical equipment.

Ultralife’s product portfolio includes lithium primary and rechargeable batteries, custom battery assemblies, military battery systems, charging equipment and accessories.